Pages

▼
Thursday, December 18, 2025

Drug Channels News Roundup, December 2025: The Net Pricing Drug Channel (#NPDC) Era, LillyDirect, My $0.02 on New MFPs, PBMs in Medicaid—and DCLF 2026

›
Happy New Year, everyone! As always, thank you for welcoming Drug Channels into your inboxes, browsers, and apps. I’m continually inspired...
Tuesday, December 16, 2025

340B Hit $81 Billion in 2024: Why CMS and the IRA Are Poised to Cool the Program’s Runaway Growth (VIDEO)

›
Yesterday, I published 340B Hit $81 Billion in 2024 (+23%): Why CMS and the IRA Are Poised to Cool the Program’s Runaway Growth . For those ...
Monday, December 15, 2025

340B Hit $81 Billion in 2024 (+23%): Why CMS and the IRA Are Poised to Cool the Program’s Runaway Growth

›
Whoa. The 340B Drug Pricing Program has once again given new meaning to the word “skyrocketing.” For 2024, discounted purchases under the 3...
Friday, December 12, 2025

Gross-to-Net Bubble Hits $356B in 2024—But Growth Slows to 10-Year Low (rerun)

›
This week, I’m rerunning some popular posts while I prepare for today’s live video webinar: Drug Channels outlook 2026 . I'll be discuss...
Thursday, December 11, 2025

The Future of Buy-and-Bill Market Access: Five Drivers of Wholesalers’ Vertical Integration with Physician Practices (rerun)

›
This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: Drug Channels Outlook 2026 . Click here...
Wednesday, December 10, 2025

Who Will Pay for Prescription Drugs in 2033: DCI’s Takeaways from the Latest Government Forecasts (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday's live video webinar: Drug Channels Outlook 2026 . Click here t...
Tuesday, December 09, 2025

Follow the 340B Dollar: Senator Cassidy Exposes How CVS Health and Walgreens Profit as 340B Contract Pharmacies (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channels Outlook 2026 . Today's rerun...
Monday, December 08, 2025

How Large PBMs Make Money Today: A 2025 Drug Channels Update (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channels Outlook 2026 . Today's rerun...
Friday, December 05, 2025

Closing the Specialty Access Gap: How GoodRx Turns Intent Into Therapy Starts

›
Today’s guest post comes from Laura Jensen, Chief Commercial Officer and President, Pharma Solutions at GoodRx Laura explores the structu...
Tuesday, December 02, 2025

List Price Reductions Will Deflate the Gross-to-Net Bubble–and Threaten Pharmacy and 340B Profits from IRA-Negotiated Drugs

›
Contrary to popular belief, the Inflation Reduction Act’s (IRA) maximum fair prices (MFPs) could temporarily boost profits for retail pharma...
Thursday, November 20, 2025

The Hidden Burdens of Cancer Care: When Insurers Override Doctors

›
Today’s guest post comes from Josh Schwartz, Vice President, Medical Affairs, North America at BeOne Medicines and Matt Shaulis, General M...
Tuesday, November 18, 2025

Drug Channels News Roundup, November 2025: PBM Revolution, Cuban’s Stelara Challenge, Express Scripts’ Price Games, U.S. Drug Spending Reality, and the AFP Reckoning

›
Happy Thanksgiving, everyone! Before you stretch your stomach, stretch your mind with some fresh food for thought from across the drug chann...